glp-1 drugs and breast cancer cut risk by 30%? Not so fast GLP-1 Drugs and Breast Cancer:

Prescription weight loss medications: GLP-1 medications like Mounjaro have extensive clinical evidence showing 15-25% weight loss

Common GLP-1 receptor agonist medications include semaglutide drugs such as Ozempic, Wegovy, and Rybelsus, as well as tirzepatide medications including Mounjaro and Zepbound

(25) GLP-1 Effects on Wound Healing A Werkmen et al

however, this methodology has inherent limitations.182 Furthermore, the guidelines do not differentiate recommendations based on the indication for GLP-1RAs use (eg, diabetes versus obesity) or the specific surgical procedure.74 In cases where patients report gastrointestinal symptoms on the day of surgery, postponement of the procedure is recommended.74 If patients do not adhere to the discontinuation recommendations, the Task Force advises implementing comprehensive gastric protective measures or considering the preoperative assessment of gastric volume via ultrasound

Lu SC, Chen M, Atangan L, Killion EA, Komorowski R, Cheng Y, et al

Consumers may wish to ask which pharmacy compounds the medication, whether third-party testing is performed, what is tested (such as sterility or potency), and how often testing occurs